InvestorsHub Logo
Followers 13
Posts 4344
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Monday, 11/16/2020 6:15:45 PM

Monday, November 16, 2020 6:15:45 PM

Post# of 18220
The merger with Cytocom will allow Immune Therapeutics to add the strength of their science and bright perspectives associated with Entolimod development in cancer treatment and radiation defense arenas with a string of immunomodulators developed by Cytocom to form a powerful blend of conceptually and scientifically aligned products.$IMUN